文献速递妇产影像儿科影像心血管

孕前糖尿病主要先天性心脏病风险受糖化血红蛋白影响

Risk of major congenital heart disease in pregestational maternal diabetes is modified by hemoglobin A1c.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-02-06

在加拿大阿尔伯塔省594773例出生中,孕前糖尿病孕妇后代主要先天性心脏病风险为无糖尿病者的2.8倍,且风险随孕早期糖化血红蛋白升高而增加,糖化血红蛋白>8.0%者调整相对风险达8.5。

要点

  • 孕前糖尿病孕妇后代主要先天性心脏病风险为无糖尿病者的2.8倍。
  • 孕早期糖化血红蛋白>8.0%时主要先天性心脏病调整相对风险为8.5。
  • 高龄及多胎妊娠亦与主要先天性心脏病风险相关。

核心结论

  • 孕前糖尿病与主要先天性心脏病相对风险2.8相关,糖化血红蛋白>8.0%时增至8.5。

研究设计与样本

  • 基于加拿大阿尔伯塔省围产健康项目登记数据的队列研究,纳入594773例出生,链接糖尿病状态、孕16周前最大糖化血红蛋白及其他协变量。

诊断标准与关键数值

  • 主要先天性心脏病定义为出生1年内需手术或导致妊娠终止或胎儿死亡。
  • 孕前糖尿病孕妇主要先天性心脏病发生率为48/7497(6.4/1000),相对风险2.8(95%CI 2.1-3.7),P<0.0001。
  • 糖化血红蛋白≤6.1%、>6.1-8.0%、>8.0%分层的主要先天性心脏病风险分别为4.2/1000、6.8/1000、17.1/1000。
  • 孕前糖尿病且糖化血红蛋白>8.0%者调整相对风险8.5(95%CI 5.0-14.4)对比无糖尿病者,5.5(95%CI 1.6-19.4)对比糖化血红蛋白正常(≤6.1%)的孕前糖尿病者。
  • 高龄调整相对风险1.03(95%CI 1.02-1.04),P<0.0001;多胎妊娠调整相对风险1.37(95%CI 1.1-1.8),P=0.02。

临床应用与阅片要点

  • 作者认为这些数据应有助于完善高危妊娠筛查的转诊指征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The association between pregestational diabetes mellitus (PDM) and risk of congenital heart disease (CHD) is well recognized; however, the importance of glycemic control and other coexisting risk factors during pregnancy is less clear. We sought to determine the relative risk (RR) of major CHD (mCHD) among offspring from pregnancies complicated by PDM and the effect of first-trimester glycemic control on mCHD risk.

METHODS: We determined the incidence of mCHD (requiring surgery within 1 year of birth or resulting in pregnancy termination or fetal demise) among registered births in Alberta, Canada. Linkage of diabetes status, maximum hemoglobin A1c (HbA1c) at < 16 weeks' gestation and other covariates was performed using data from the Alberta Perinatal Health Program registry. Risk of mCHD according to HbA1c was estimated as an adjusted RR (aRR), calculated using log-binomial modeling.

RESULTS: Of 1412 cases of mCHD in 594 773 (2.37/1000) births in the study period, mCHD was present in 48/7497 with PDM (6.4/1000; RR, 2.8 (95% CI, 2.1-3.7); P < 0.0001). In the entire cohort, increased maternal age (aRR, 1.03 (95% CI, 1.02-1.04); P < 0.0001) and multiple gestation (aRR, 1.37 (95% CI, 1.1-1.8); P = 0.02) were also associated with mCHD risk, whereas maternal prepregnancy weight > 91 kg was not. The stratified risk for mCHD associated with HbA1c ≤ 6.1%, > 6.1-8.0% and > 8.0% was 4.2/1000, 6.8/1000 and 17.1/1000 PDM/gestational diabetes mellitus births, respectively; the aRR of mCHD associated with PDM and HbA1c > 8.0% was 8.5 (95% CI, 5.0-14.4) compared to those without diabetes and 5.5 (95% CI, 1.6-19.4) compared to PDM with normal HbA1c (≤ 6.1%).

CONCLUSIONS: PDM is associated with a RR of 2.8 for mCHD, increasing to 8.5 in those with HbA1c > 8%. These data should facilitate refinement of referral indications for high-risk pregnancy screening. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. He R, Hornberger LK, Kaur A, et al. Risk of major congenital heart disease in pregestational maternal diabetes is modified by hemoglobin A1c. Ultrasound Obstet Gynecol. 2024. PMID: 37594210. doi:10.1002/uog.27456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。